PubMed Health⌕ Search

Biomedical subjects

F Di Lollo

Publications and source records attributed to F Di Lollo.

At least 19 recordsLinked to original sources
PubMed1983

[Hemodilution and plasmapheresis in the therapy of hyperviscosity syndromes].

The results obtained using hemodilution, plasmapheresis, plasma-exchange and erythro-apheresis in the treatment of several diseases with hyperviscosity syndrome are discussed. These therapeutic approaches seem very useful not only in the treatment of hyperviscosity syndrome, but also in the prevention of vascular damage.

Adult↗
PubMed1977

[Desferrioxamine in the diagnosis of hypo-, normo-, and hypersiderotic hyposideremia].

Evaluation of stored iron by means of DFOX-induced sideruria in 101 subjects with various degree of hyposideraemia with or without anaemia, is reported. Three groups were examined: 49 patients with chronic loss of blood and malabsorption and urinary iron values up to 1 mg/24hr; 43 with non-bleeding neoplasia, collagen disease, lymphoma, cirrhosis of the liver etc. and values of 1-2mg/24 hr; 9 with rheumatoid arthritis and cirrhosis of the liver and values over 2 mg/24 hr. The reasons why hyposideraemia may accompany incipient of frank tissue hypo-, normo- or hypersiderosis are discussed.

Adult↗
PubMed1976

[The problem of dissecting aneurysm of the aorta and its benign course].

On the basis of a personal case, the clinical, diagnostic and therapeutic problems of variants of dissecting aneurysm of the aorta with benign course are discussed. The usefulness of cardio-aortic angioscintigraphy in the interests of early diagnosis of aneurysm and aortography by catheterism for specifying its location and extent, is pointed out. Spontaneous benign development would seem to be tied up with the affected area of the aorta, the modalities of dissection, and above all with the establishment of a distal return breach for blood flow into the aortic lumen. The predominant role of cystic medionecrosis in determining dissection is stressed and the usefulness of intensive pharmacological therapy based essentially on hypotensive and beta-blocking substances confirmed.

Adrenergic beta-Antagonists↗